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• Impact Of COVID-19 In Healthcare Supply Chain
• U.S. Response To COVID-19 & PPE Shortages
• Covid-19 Data Management In The U.S.
• Prediction Models Based On PPE Needs
• Discussion & Conclusion
INTRODUCTION
Since the first case of the new coronavirus was reported on November 2019 in 
China, approximately 147 million people have been diagnosed resulting in over 
3.11million deaths . About 22% of these deaths were in the US .
32,092,128





SHORTAGES OF PPE for doctors and nurses
were major news stories nightly on news
broadcasts with pictures of doctors and nurses
wearing trash bags as substitute gowns and
homemade masks that offered little protection
OVER SIX THOUSAND HOSPITALS as well as
all fifty states competed with each other for
Personal Protective Equipment in the U.S.
THE COVID-19 pandemic caused 
massive shortages in the Personal 
Protective Equipment (PPE) supplies 
needed to treat the virus as the disease 
spread rapidly throughout the world during 
2020. Global supply chains suddenly 
became a new problem in public attention. 

SITUATION
Even though we had seen the devastation of COVID-19 in China and other
countries, the United States was totally unprepared when the virus started
spreading rapidly here.
Hospitals had less than
2 days of PPE on hand
Many ran out of PPE in 
the first few days
CHALLENGES
A major challenge was the disruption to the 
PPE supply chains in the U.S. and large 
PPE shortages across the country.
A second challenge was the lack of an 
accurate database of the production 
capabilities of U.S. suppliers of PPE.
SUPPLY CHAIN CHALLENGES IN HEALTHCARE 
Costs Lack Of Supply Chain Health 
Information Technologies
Lack Of Quality
IMPACT OF COVID-19 PANDEMIC IN 
THE HEALTHCARE SUPPLY CHAIN
• The practice of many healthcare organizations 
was purchasing using just-in-time delivery from 
Group Purchasing Organizations.
• Suppliers who normally produced based on a 
predictable and regular demand struggled to 
change their production processes to meet the 
rapid changes in demand.
• Around 50% of masks used in the world are 
made in one country, China. As the virus hit China 
first, the lockdowns there diverted supplies and 
paused production causing significant shortages 
of masks throughout the world.
JUST-IN-TIME DELIVERY THE GLOBAL NATURE 
OF THE MEDICAL SUPPLY CHAIN
U.S. RESPONSE TO COVID-19
Travel Restriction Screening at the port of entry and mandatory home 
quarantine was implemented for travelers.
The U.S. second action was stay home orders instructing 
citizens to restrict their commuting outside their homes if not 
required.
Stay Home
Social distancing and wearing masks in public areas was also 
recommended by the U.S. government and the CDC. 
Social Distancing
Wearing Masks
US RESPONSE TO PPE SHORTAGES
TEXTILES & APPAREL COMPANIES
• Many apparel companies quickly turned their production
lines to masks and gowns.
• Nonwovens companies retooled production facilities to
produce the three-layer fabrics needed for N95 masks.
• Many companies that did not previously produce PPE,
such as Ralph Lauren and Canada Goose adjusted their
operations to produce critically needed products.
UNIVERSITIES
Many universities in the U.S. reacted quickly to PPE 
shortages.
Some made masks by hand, others revamped research 
facilities into manufacturing production operations.
TEXTILES & NON-TEXTILES MANUFACTURES
Many non-textile manufacturers, e.g., Ford and 
Honeywell, also responded to contribute to the 
manufacture of PPE. 
• Increasing manufacture of finished PPE and 
healthcare products.
• Increasing manufacture of components
needed to make PPE: 
– Yarns and thread
– Fabrics
– Antibacterial and durable water repellent 
finishes 
COVID-19 DATA MANAGEMENT IN THE U.S.
Many different data management tools were 
used to identify PPE needs and Demands:
• Data Tracking
• Contact Tracing
• The Strategic National Stockpile
The right data help to evaluate existing situations, predict 
upcoming crises and make critical decisions
The current PPE NEEDS and
DEMANDS were identified using
the data on patients in hospitals,
in states, and in regions of the
country.
PREDICTION MODELS BASED ON PPE NEEDS
HIGH DEMAND of critical products and
SHORTAGES IN SUPPLY had a major
impact on healthcare supply chains.
Many of the operational problems during
the COVID-19 pandemic stem from the
current supply chain management systems
that have been primarily designed for
COST EFFICIENCIES.
The challenges managing supply 
chains during a pandemic require 
FLEXIBLE SYSTEMS designed to 
quickly adapt to a rapidly changing 
landscape.
THREE SHORTAGE EXAMPLES
PROTECTIVE GOWNS FACE SHIELDS  N95 RESPIRATORS 
High percentage of hospital gowns 
made by one U.S. company 
Fabric suppliers in Central America 
had been closed and existing fabric 
supplies were soon exhausted
Several companies responded to the 
crisis providing millions of yards of 
high-quality fabric for production of 
gowns
Low-cost supplies were soon 
available again from other countries
The U.S. manufacturers were left 
holding millions of yards of fabric in 
unsold inventories
The shortages of these critical 
PPE items were so serious that 
many healthcare workers were 
asked to wear theirs for several 
days or even weeks or resorted 
to wearing the less efficient 
surgical masks or even 
homemade cloth masks
The shield makers, almost all not 
connected to the apparel and textile 
manufacturing complex, found 
themselves competing with the 
manufactures of surgical face 
masks and N95 respirators for 
short-supply narrow-width, elastic 
fabrics used as head bands for the 
shields. 
Many organizations, especially 
research labs in universities, 
have numerous 3D printers. 
Designs for the face shields were 
rapidly shared and soon tens of 
thousands of face shields were 
being produced.
Although the United States is still 
the number one producer of 
nonwovens in the world, almost 
all plants were already running at 
close to full capacity prior to the 
pandemic with many making 
other critical healthcare supplies. 
THREE SHORTAGE EXAMPLES
Almost all the critical PPE could be manufactured in the United States and distributed quickly to 
the healthcare providers and others with critical needs. 
No producer of the end items controlled the supply chains end-to-end needed to produce these 
items.
Most producers were concerned that critical elements of the supply chain would revert to the 
lowest cost producers outside the U.S. as soon as possible and were reluctant to invest.
Most potential producers of PPE were concerned that they would not be able to recoup their 
investments in new equipment or facilities as purchasers would revert to sourcing the lowest 
cost products as soon as they could.
OTHER COUNTRIES
Other countries countered the above concerns in several ways. 
• Taiwan created an adequate supply of face masks quickly be providing loans for new 
equipment that would be forgiven after a specified number of masks were provided to the 
government. This strategy worked amazingly well. Not only were the supplies created for 
use in Taiwan quickly, but these companies also soon became exporters of the masks to 
other countries still facing shortages.
• The U.K. also faced severe shortages but used a different approach. The government 
guaranteed purchase of many critical PPE items if manufacturers quickly ramped up 
production to provide what was needed. This is almost the identical approach the US used 
for accelerating the creation and production of the vaccines by Pfizer. 
• Some countries just made direct grants for needed equipment to encourage companies to 
become capable of producing needed PPE.
LACK OF QULITY
Compounding these problems was the lack of reliable test facilities for assuring that the 
products created or rapidly sourced from new suppliers and distributors met the 
QUALITY standards created by the FDA, CDC and NIOSH. 
Some healthcare providers enlisted labs at local universities to provide basic testing on 




Future healthcare materials acquisition 
programs should be based on much 
deeper understandings of the entire 
supply chain.
Clear specifications not just for end 
products but also for intermediate 
materials must be developed. 
Quality measurement plans and 
adequate testing facilities must be 




This work has implications for 
anyone in the healthcare supply 
chain space (DoD task forces, 
DLA, DHA, FEMA, DHHS, DHS, 
State, Local and healthcare 
systems). 
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